Brain iron overload following intracranial haemorrhage

Stroke and Vascular Neurology

Volumn 1, Issue 4, 2016, Pages 172-184

  Garton, Thomas ^a   Keep, Richard F ^a   Hua, Ya ^a   Xi, Guohua ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; IRON CHELATING AGENT;

ANIMAL; BRAIN; BRAIN HEMORRHAGE; COMPLICATION; DRUG EFFECT; HOMEOSTASIS; HUMAN; IRON OVERLOAD; METABOLISM; PATHOLOGY; PROGNOSIS;

ANIMALS; BRAIN; HOMEOSTASIS; HUMANS; INTRACRANIAL HEMORRHAGES; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; PROGNOSIS;

EID: 85032150824     PISSN: 20598688     EISSN: 20598696     Source Type: Journal    
DOI: 10.1136/svn-2016-000042     Document Type: Review

References (217)

1. Kuhn LC. Iron regulatory proteins and their role in controlling iron metabolism. Metallomics 2015;7:232-43.
2. Quintana C, Bellefqih S, Laval JY, et al. Study of the localization of iron, ferritin, and hemosiderin in alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 2006;153:42-54.
3. Berg D. In vivo detection of iron and neuromelanin by transcranial sonography-a new approach for early detection of substantia nigra damage. J Neural Transm (Vienna) 2006;113:775-80.
4. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-93.
5. Nilsson OG, Lindgren A, Stahl N, et al. Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatr 2000;69:601-7.
6. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 2012;11:720-31.
7. Garton T, Keep RF, Wilkinson DA, et al. Intraventricular hemorrhage: the role of blood components in secondary injury and hydrocephalus. Transl Stroke Res 2016;7:447-51.
8. Xiong XY, Wang J, Qian ZM, et al. Iron and intracerebral hemorrhage: from mechanism to translation. Transl Stroke Res 2014;5:429-41.
9. Bradbury MW. Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 1997;69:443-54.
10. Connor JR, Menzies SL, Burdo JR, et al. Iron and iron management proteins in neurobiology. Pediatr Neurol 2001;25:118-29.
11. Aisen P, Leibman A, Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. J Biol Chem 1978;253:1930-7.
12. Ke Y, Qian ZM. Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 2007;83:149-73.
13. Qian ZM, Tang PL, Wang Q. Iron crosses the endosomal membrane by a carrier-mediated process. Prog Biophys Mol Biol 1997;67:1-15.
14. Yu Z, Persson HL, Eaton JW, et al. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic Biol Med 2003;34:1243-52.
15. Arosio P, Carmona F, Gozzelino R, et al. The importance of eukaryotic ferritins in iron handling and cytoprotection. Biochem J 2015;472:1-15.
16. Moos T, Rosengren Nielsen T, Skjorringe T, et al. Iron trafficking inside the brain. J Neurochem 2007;103:1730-40.
17. Wong BX, Tsatsanis A, Lim LQ, et al. Beta-amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE 2014;9: e114174.
18. Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in alzheimer's disease. Cell 2010;142:857-67.
19. Guo S, Frazer DM, Anderson GJ. Iron homeostasis: transport, metabolism, and regulation. Curr Opin Clin Nutr Metab Care 2016;19:276-81.
20. Aisen P, Leibman A. Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta 1972;257:314-23.
21. Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 1998;27:257-67.
22. Terent A, Hallgren R, Venge P, et al. Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation. Stroke 1981;12:40-6.
23. Rogers JT, Randall JD, Cahill CM, et al. An iron-responsive element type II in the 5'-untranslated region of the alzheimer's amyloid precursor protein transcript. J Biol Chem 2002;277:45518-28.
24. Gray NK, Hentze MW. Iron regulatory protein prevents binding of the 43s translation pre-initiation complex to ferritin and ealas mrnas. EMBO J 1994;13:3882-91.
25. Guo B, Yu Y, Leibold EA. Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J Biol Chem 1994;269:24252-60.
26. Gunshin H, Allerson CR, Polycarpou-Schwarz M, et al. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett 2001;509:309-16.
27. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
28. Li L, Holscher C, Chen BB, et al. Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus. Biol Trace Elem Res 2011;143:1581-93.
29. Tan G, Liu L, He Z, et al. Role of hepcidin and its downstream proteins in early brain injury after experimental subarachnoid hemorrhage in rats. Mol Cell Biochem 2016;418:31-8.
30. Rochette L, Gudjoncik A, Guenancia C, et al. The iron-regulatory hormone hepcidin: a possible therapeutic target? Pharmacol Ther 2015;146:35-52.
31. Zhang AS, Enns CA. Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem 2009;284:711-15.
32. Biagioli M, Pinto M, Cesselli D, et al. Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci USA 2009;106:15454-9.
33. Liu L, Zeng M, Stamler JS. Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci USA 1999;96:6643-7.
34. Schelshorn DW, Schneider A, Kuschinsky W, et al. Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab 2009;29:585-95.
35. Richter F, Meurers BH, Zhu C, et al. Neurons express hemoglobin alpha- and beta-chains in rat and human brains. J Comp Neurol 2009;515:538-47.
36. Saha D, Patgaonkar M, Shroff A, et al. Hemoglobin expression in nonerythroid cells: novel or ubiquitous? Int J Inflam 2014;2014:803237.
37. Wicher KB, Fries E. Evolutionary aspects of hemoglobin scavengers. Antioxid Redox Signal 2010;12:249-59.
38. Thomsen JH, Etzerodt A, Svendsen P, et al. The haptoglobin-cd163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid Med Cell Longev 2013;2013:523652.
39. Alayash AI. Haptoglobin: old protein with new functions. Clin Chim Acta 2011;412:493-8.
40. Graversen JH, Madsen M, Moestrup SK. Cd163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 2002;34:309-14.
41. Borda JT, Alvarez X, Mohan M, et al. Cd163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood- brain barrier. Am J Pathol 2008;172:725-37.
42. Etzerodt A, Moestrup SK. Cd163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 2013;18:2352-63.
43. Moller HJ. Soluble cd163. Scand J Clin Lab Invest 2012;72:1-13.
44. Qian M, Shen X, Wang H. The distinct role of adam17 in app proteolysis and microglial activation related to alzheimer's disease. Cell Mol Neurobiol 2016;36:471-82.
45. Lisi S, D'Amore M, Sisto M. Adam17 at the interface between inflammation and autoimmunity. Immunol Lett 2014;162:159-69.
46. Garton TP, He Y, Garton HJ, et al. Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhage. Brain Res 2016;1635:86-94.
47. Chen-Roetling J, Regan RF. Haptoglobin increases the vulnerability of cd163-expressing neurons to hemoglobin. J Neurochem 2016;139:586-95.
48. Fruitier I, Garreau I, Lacroix A, et al. Proteolytic degradation of hemoglobin by endogenous lysosomal proteases gives rise to bioactive peptides: hemorphins. FEBS Lett 1999;447:81-6.
49. Schaer CA, Schoedon G, Imhof A, et al. Constitutive endocytosis of cd163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res 2006;99:943-50.
50. Kaliman PA, Barannik TB. [heme metabolism and oxidative stress]. Ukr Biokhim Zh (1999) 2001;73:5-15.
51. Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 1999;31:335-40.
52. Unno M, Matsui T, Ikeda-Saito M. Crystallographic studies of heme oxygenase complexed with an unstable reaction intermediate, verdoheme. J Inorg Biochem 2012;113:102-9.
53. Watchko JF. Bilirubin-induced neurotoxicity in the preterm neonate. Clin Perinatol 2016;43:297-311.
54. O'Brien L, Hosick PA, John K, et al. Biliverdin reductase isozymes in metabolism. Trends Endocrinol Metab 2015;26:212-20.
55. Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet 2009;8:355-69.
56. Ikram MA, Wieberdink RG, Koudstaal PJ. International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 2012;14:300-6.
57. van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet 2010;9:167-76.
58. Perez de la Ossa N, Sobrino T, Silva Y, et al. Iron-related brain damage in patients with intracerebral hemorrhage. Stroke 2010;41:810-3.
59. Wagner KR, Sharp FR, Ardizzone TD, et al. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 2003;23:629-52.
60. Zhao X, Song S, Sun G, et al. Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 2009;29:15819-27.
61. Kress GJ, Dineley KE, Reynolds IJ. The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci 2002;22:5848-55.
62. Regan RF, Chen M, Li Z, et al. Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin. Neurobiol Dis 2008;31:242-9.
63. Musci G, Polticelli F, Bonaccorsi di Patti MC. Ceruloplasminferroportin system of iron traffic in vertebrates. World J Biol Chem 2014;5:204-15.
64. Roeser HP, Lee GR, Nacht S, et al. The role of ceruloplasmin in iron metabolism. J Clin Invest 1970;49:2408-17.
65. Tolosano E, Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 2002;21:297-306.
66. Camborieux L, Julia V, Pipy B, et al. Respective roles of inflammation and axonal breakdown in the regulation of peripheral nerve hemopexin: an analysis in rats and in c57bl/wlds mice. J Neuroimmunol 2000;107:29-41.
67. Wang G, Manaenko A, Shao A, et al. Low-density lipoprotein receptor-related protein-1 facilitates heme scavenging after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab Published Online First: 17 Jun 2016.
68. Garland P, Durnford AJ, Okemefuna AI, et al. Heme-hemopexin scavenging is active in the brain and associates with outcome after subarachnoid hemorrhage. Stroke 2016;47:872-6.
69. Moestrup SK, Gliemann J, Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992;269:375-82.
70. Hvidberg V, Maniecki MB, Jacobsen C, et al. Identification of the receptor scavenging hemopexin-heme complexes. Blood 2005;106:2572-9.
71. Nielsen MJ, Moller HJ, Moestrup SK. Hemoglobin and heme scavenger receptors. Antioxid Redox Signal 2010;12:261-73.
72. Cho HH, Cahill CM, Vanderburg CR, et al. Selective translational control of the alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem 2010;285:31217-32.
73. Schenck JF, Zimmerman EA. High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004;17:433-45.
74. Koeppen AH, Michael SC, Li D, et al. The pathology of superficial siderosis of the central nervous system. Acta Neuropathol 2008;116:371-82.
75. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet 2009;8:165-74.
76. Hahl P, Davis T, Washburn C, et al. Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states. J Neurochem 2013;125:89-101.
77. Ma B, Day JP, Phillips H, et al. Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage. J Neuroinflammation 2016;13:26.
78. Chen L, Zhang X, Chen-Roetling J, et al. Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J Neurosurg 2011;114:1159-67.
79. Gaasch JA, Lockman PR, Geldenhuys WJ, et al. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 2007;32:1196-208.
80. Welch KD, Davis TZ, Van Eden ME, et al. Deleterious iron-mediated oxidation of biomolecules. Free Radic Biol Med 2002;32:577-83.
81. Calabrese V, Lodi R, Tonon C, et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 2005;233:145-62.
82. Shamoto-Nagai M, Maruyama W, Yi H, et al. Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26s proteasome. J Neural Transm (Vienna) 2006;113:633-44.
83. Park J, Lee DG, Kim B, et al. Iron overload triggers mitochondrial fragmentation via calcineurin-sensitive signals in HT-22 hippocampal neuron cells. Toxicology 2015;337:39-46.
84. Cho B, Choi SY, Cho HM, et al. Physiological and pathological significance of dynamin-related protein 1 (Drp1)-dependent mitochondrial fission in the nervous system. Exp Neurobiol 2013;22:149-57.
85. Slupe AM, Merrill RA, Flippo KH, et al. A calcineurin docking motif (LXVP) in dynamin-related protein 1 contributes to mitochondrial fragmentation and ischemic neuronal injury. J Biol Chem 2013;288:12353-65.
86. Cereghetti GM, Stangherlin A, Martins de Brito O, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 2008;105:15803-8.
87. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet 2006;5:53-63.
88. Zazulia AR, Diringer MN, Derdeyn CP, et al. Progression of mass effect after intracerebral hemorrhage. Stroke 1999;30:1167-73.
89. Cook JD. Defining optimal body iron. Proc Nutr Soc 1999;58:489-95.
90. Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta 2010;1800:760-9.
91. Mehdiratta M, Kumar S, Hackney D, et al. Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage. Stroke 2008;39:1165-70.
92. Bakhshayesh B, Hosseininezhad M, Saadat SN, et al. Iron overload is associated with perihematoma edema growth following intracerebral hemorrhage that may contribute to in-hospital mortality and long-term functional outcome. Curr Neurovasc Res 2014;11:248-53.
93. Hua Y, Keep RF, Hoff JT, et al. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab 2003;23:1448-54.
94. Yang G, Hu R, Zhang C, et al. A combination of serum iron, ferritin and transferrin predicts outcome in patients with intracerebral hemorrhage. Sci Rep 2016;6:21970.
95. Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase c zeta/nuclear factor kappab-regulated signaling in rat hepatic stellate cells. Hepatology 2009;49:887-900.
96. Wang G, Hu W, Tang Q, et al. Effect comparison of both iron chelators on outcomes, iron deposit, and iron transporters after intracerebral hemorrhage in rats. Mol Neurobiol 2016;53:3576-85.
97. Taniguchi M, Yamashita T, Kumura E, et al. Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res 2000;78:131-7.
98. Mao J, Yu JL, Fu XM, et al. [Changes on the expression of aquaporin-4 is associated with edema of brain in neonatal rats subjected to hypoxic ischemic brain damage]. Sichuan Da Xue Xue Bao Yi Xue Ban 2014;45:386-9, 409.
99. Nagelhus EA, Ottersen OP. Physiological roles of aquaporin-4 in brain. Physiol Rev 2013;93:1543-62.
100. Saadoun S, Papadopoulos MC, Davies DC, et al. Aquaporin-4 expression is increased in oedematous human brain tumours. J Neurol Neurosurg Psychiatry 2002;72:262-5.
101. Tang Y, Wu P, Su J, et al. Effects of aquaporin-4 on edema formation following intracerebral hemorrhage. Exp Neurol 2010;223:485-95.
102. Qing WG, Dong YQ, Ping TQ, et al. Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. J Neurosurg 2009;110:462-8.
103. Ximenes-da-Silva A. Metal ion toxins and brain aquaporin-4 expression: an overview. Front Neurosci 2016;10:233.
104. Wang LF, Yokoyama KK, Chen TY, et al. Male-specific alleviation of iron-induced striatal injury by inhibition of autophagy. PLoS ONE 2015;10:e0131224.
105. Tanida I, Ueno T, Kominami E. Lc3 and autophagy. Methods Mol Biol 2008;445:77-88.
106. He Y, Wan S, Hua Y, et al. Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 2008;28:897-905.
107. Wang LF, Yokoyama KK, Lin CL, et al. Knockout of ho-1 protects the striatum from ferrous iron-induced injury in a male-specific manner in mice. Sci Rep 2016;6:26358.
108. Zukor H, Song W, Liberman A, et al. Ho-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem 2009;109:776-91.
109. Zhang Z, Miah M, Culbreth M, et al. Autophagy in neurodegenerative diseases and metal neurotoxicity. Neurochem Res 2016;41:409-22.
110. Chew KC, Ang ET, Tai YK, et al. Enhanced autophagy from chronic toxicity of iron and mutant A53T alpha-synuclein: implications for neuronal cell death in Parkinson disease. J Biol Chem 2011;286:33380-9.
111. Kamalinia G, Khodagholi F, Atyabi F, et al. Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies. Mol Pharm 2013;10:4418-31.
112. Matsushita K, Meng W, Wang X, et al. Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J Cereb Blood Flow Metab 2000;20:396-404.
113. Karwacki Z, Kowianski P, Dziewatkowski J, et al. Apoptosis in the course of experimetal intracerebral haemorrhage in the rat. Folia Morphol (Warsz) 2005;64:248-52.
114. Levy YS, Streifler JY, Panet H, et al. Hemin-induced apoptosis in PC12 and neuroblastoma cells: implications for local neuronal death associated with intracerebral hemorrhage. Neurotox Res 2002;4:609-16.
115. Sun H, Li L, Zhou F, et al. The member of high temperature requirement family HtrA2 participates in neuronal apoptosis after intracerebral hemorrhage in adult rats. J Mol Histol 2013;44:369-79.
116. Yuan D, Shen J, Yan Y, et al. Upregulated expression of sstr1 is involved in. neuronal apoptosis and is coupled to the reduction of bcl-2 following intracerebral hemorrhage in adult rats. Cell Mol Neurobiol 2014;34:951-61.
117. Shen J, Liu Y, Song Y, et al. CHMP4b, ESCRT-III associating protein, associated with neuronal apoptosis following intracerebral hemorrhage. Brain Res 2015;1597:1-13.
118. Zhang D, Yuan D, Shen J, et al. Up-regulation of VCAM1 relates to neuronal apoptosis after intracerebral hemorrhage in adult rats. Neurochem Res 2015;40:1042-52.
119. Chen X, Shen J, Wang Y, et al. Up-regulation of c-Fos associated with neuronal apoptosis following intracerebral hemorrhage. Cell Mol Neurobiol 2015;35:363-76.
120. Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;149:1060-72.
121. Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell Mol Life Sci 2016;73:2195-209.
122. Chang CF, Cho S, Wang J. (-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Ann Clin Transl Neurol 2014;1:258-71.
123. Ying W, Han SK, Miller JW, et al. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem 1999;73:1549-56.
124. Bishop GM, Robinson SR. Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 2001;907:175-87.
125. Siesjo BK, Agardh CD, Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989;1:165-211.
126. Baader SL, Bruchelt G, Carmine TC, et al. Ascorbic-acid-mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastoma cells. J Cancer Res Clin Oncol 1994;120:415-21.
127. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010;67:1-8.
128. Bhattathiri PS, Gregson B, Prasad KS, et al. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl 2006;96:65-8.
129. Rosen DS, Macdonald RL, Huo D, et al. Intraventricular hemorrhage from ruptured aneurysm: clinical characteristics, complications, and outcomes in a large, prospective, multicenter study population. J Neurosurg 2007;107:261-5.
130. Savman K, Nilsson UA, Blennow M, et al. Non-protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation. Pediatr Res 2001;49:208-12.
131. Fukumizu M, Takashima S, Becker LE. Glial reaction in periventricular areas of the brainstem in fetal and neonatal posthemorrhagic hydrocephalus and congenital hydrocephalus. Brain Dev 1996;18:40-5.
132. Gao C, Du H, Hua Y, et al. Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage. J Cereb Blood Flow Metab 2014;34:1070-5.
133. Strahle JM, Garton T, Bazzi AA, et al. Role of hemoglobin and iron in hydrocephalus after neonatal intraventricular hemorrhage. Neurosurgery 2014;75:696-705; discussion 706.
134. Chen Z, Gao C, Hua Y, et al. Role of iron in brain injury after intraventricular hemorrhage. Stroke 2011;42:465-70.
135. Giometto B, Bozza F, Argentiero V, et al. Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci 1990;98:81-90.
136. Lu J, Kaur C, Ling EA. Expression and upregulation of transferrin receptors and iron uptake in the epiplexus cells of different aged rats injected with lipopolysaccharide and interferon-gamma. J Anat 1995;187:603-11.
137. Kaur C, Rathnasamy G, Ling EA. The choroid plexus in healthy and diseased brain. J Neuropathol Exp Neurol 2016;75:198-213.
138. Chodobski A, Szmydynger-Chodobska J. Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech 2001;52:65-82.
139. Boassa D, Yool AJ. Physiological roles of aquaporins in the choroid plexus. Curr Top Dev Biol 2005;67:181-206.
140. Sveinsdottir S, Gram M, Cinthio M, et al. Altered expression of aquaporin 1 and 5 in the choroid plexus following preterm intraventricular hemorrhage. Dev Neurosci 2014;36:542-51.
141. Gram M, Sveinsdottir S, Cinthio M, et al. Extracellular hemoglobin -mediator of inflammation and cell death in the choroid plexus following preterm intraventricular hemorrhage. J Neuroinflammation 2014;11:200.
142. Chen Q, Tang J, Tan L, et al. Intracerebral hematoma contributes to hydrocephalus after intraventricular hemorrhage via aggravating iron accumulation. Stroke 2015;46:2902-8.
143. Meng H, Li F, Hu R, et al. Deferoxamine alleviates chronic hydrocephalus after intraventricular hemorrhage through iron chelation and wnt1/wnt3a inhibition. Brain Res 2015;1602:44-52.
144. Wirth FP. Surgical treatment of incidental intracranial aneurysms. Clin Neurosurg 1986;33:125-35.
145. Naggara O, Nataf F. [subarachnoid hemorrhage in young patients]. Rev Prat 2013;63:951-9.
146. Kotlega D, Golab-Janowska M, Masztalewicz M, et al. Potential role of statins in the intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Neurochir Pol 2015;49:322-8.
147. Lee JY, Keep RF, Hua Y, et al. Deferoxamine reduces early brain injury following subarachnoid hemorrhage. Acta Neurochir Suppl 2011;112:101-6.
148. Suzuki H, Muramatsu M, Tanaka K, et al. Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurol.2006;253:1170-6.
149. Ono S, Zhang ZD, Marton LS, et al. Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 2000;20:1066-76.
150. Gomes JA, Selim M, Cotleur A, et al. Brain iron metabolism and brain injury following subarachnoid hemorrhage: icefish-pilot (csf iron in sah). Neurocrit Care 2014;21:285-93.
151. Lee JY, Keep RF, He Y, et al. Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab 2010;30:1793-803.
152. Sripetchwandee J, Sanit J, Chattipakorn N, et al. Mitochondrial calcium uniporter blocker effectively prevents brain mitochondrial dysfunction caused by iron overload. Life Sci 2013;92:298-304.
153. Yan H, Hao S, Sun X, et al. Blockage of mitochondrial calcium uniporter prevents iron accumulation in a model of experimental subarachnoid hemorrhage. Biochem Biophys Res Commun 2015;456:835-40.
154. Wang Y, Gao A, Xu X, et al. The neuroprotection of lysosomotropic agents in experimental subarachnoid hemorrhage probably involving the apoptosis pathway triggering by cathepsins via chelating intralysosomal iron. Mol Neurobiol 2015;52:64-77.
155. Bickford JS, Ali NF, Nick JA, et al. Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism. Brain Res 2014;1588:25-36.
156. Stow LR, Jacobs ME, Wingo CS, et al. Endothelin-1 gene regulation. FASEB J 2011;25:16-28.
157. Joerk A, Seidel RA, Walter SG, et al. Impact of heme and heme degradation products on vascular diameter in mouse visual cortex. J Am Heart Assoc 2014;3:e001220.
158. Vollmer DG, Hongo K, Ogawa H, et al. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 1991;28:27-32.
159. Pluta RM, Oldfield EH. Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Rev Recent Clin Trials 2007;2:59-67.
160. Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 2008;104:33-41.
161. Yu Y, Lin Z, Yin Y, et al. The ferric iron chelator 2, 2'-dipyridyl attenuates basilar artery vasospasm and improves neurological function after subarachnoid hemorrhage in rabbits. Neurol Sci 2014;35:1413-19.
162. Corradini E, Rozier M, Meynard D, et al. Iron regulation of hepcidin despite attenuated smad1, 5, 8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 2011;141:1907-14.
163. Bruns J Jr, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia 2003;44(Suppl 10):2-10.
164. Popescu C, Anghelescu A, Daia C, et al. Actual data on epidemiological evolution and prevention endeavours regarding traumatic brain injury. J Med Life 2015;8:272-7.
165. Zhao J, Chen Z, Xi G, et al. Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats. Transl Stroke Res 2014;5:586-94.
166. Petronilho F, Feier G, de Souza B, et al. Oxidative stress in brain according to traumatic brain injury intensity. J Surg Res 2010;164:316-20.
167. Nisenbaum EJ, Novikov DS, Lui YW. The presence and role of iron in mild traumatic brain injury: an imaging perspective. J Neurotrauma 2014;31:301-7.
168. Millerot-Serrurot E, Bertrand N, Mossiat C, et al. Temporal changes in free iron levels after brain ischemia relevance to the timing of iron chelation therapy in stroke. Neurochem Int 2008;52:1442-8.
169. Justicia C, Ramos-Cabrer P, Hoehn M. MRI detection of secondary damage after stroke: chronic iron accumulation in the thalamus of the rat brain. Stroke 2008;39:1541-7.
170. Raz E, Jensen JH, Ge Y, et al. Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am J Neuroradiol 2011;32:1851-6.
171. Liu HD, Li W, Chen ZR, et al. Increased expression of ferritin in cerebral cortex after human traumatic brain injury. Neurol Sci 2013;34:1173-80.
172. Onyszchuk G, LeVine SM, Brooks WM, et al. Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci Lett 2009;452:204-8.
173. Lu L, Cao H, Wei X, et al. Iron deposition is positively related to cognitive impairment in patients with chronic mild traumatic brain injury: assessment with susceptibility weighted imaging. Biomed Res Int 2015;2015:470676.
174. Ayton S, Zhang M, Roberts BR, et al. Ceruloplasmin and beta-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron. Free Radic Biol Med 2014;69:331-7.
175. McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009;68:709-35.
176. Wang L, Xi G, Keep RF, et al. Iron enhances the neurotoxicity of amyloid beta. Transl Stroke Res 2012;3:107-13.
177. Okubo S, Xi G, Keep RF, et al. Cerebral hemorrhage, brain edema, and heme oxygenase-1 expression after experimental traumatic brain injury. Acta Neurochir Suppl 2013;118:83-7.
178. Hui Y, Wang D, Li W, et al. Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation. J Alzheimers Dis 2011;26:299-313.
179. Li H, Swiercz R, Englander EW. Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA. J Neurochem 2009;110:1774-83.
180. Gomes JA, Manno E. New developments in the treatment of intracerebral hemorrhage. Neurol Clin 2013;31:721-35.
181. Cui HJ, He HY, Yang AL, et al. Efficacy of deferoxamine in animal models of intracerebral hemorrhage: a systematic review and stratified meta-analysis. PLoS ONE 2015;10:e0127256.
182. Hua Y, Keep RF, Hoff JT, et al. Deferoxamine therapy for intracerebral hemorrhage. Acta Neurochir Suppl 2008;105:3-6.
183. Selim M. Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials. Stroke 2009;40:S90-1.
184. Zhang L, Hu R, Li M, et al. Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury. Neurol Sci 2013;34:639-45.
185. Xie Q, Gu Y, Hua Y, et al. Deferoxamine attenuates white matter injury in a piglet intracerebral hemorrhage model. Stroke 2014;45:290-2.
186. Hatakeyama T, Okauchi M, Hua Y, et al. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res 2013;4:546-53.
187. Zhou X, Xie Q, Xi G, et al. Brain CD47 expression in a swine model of intracerebral hemorrhage. Brain Res 2014;1574:70-6.
188. Chun HJ, Kim DW, Yi HJ, et al. Effects of statin and deferoxamine administration on neurological outcomes in a rat model of intracerebral hemorrhage. Neurol Sci 2012;33:289-96.
189. Wu H, Wu T, Xu X, et al. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab 2011;31:1243-50.
190. Selim M, Yeatts S, Goldstein JN, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke 2011;42:3067-74.
191. Yeatts SD, Palesch YY, Moy CS, et al. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care 2013;19:257-66.
192. Yu Y, Zhao W, Zhu C, et al. The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage. PLoS ONE 2015;10:e0122371.
193. Klein NC, Cunha BA. Tetracyclines. Med Clin North Am 1995;79:789-801.
194. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 2001;166:7527-33.
195. Tikka T, Fiebich BL, Goldsteins G, et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001;21:2580-8.
196. Wasserman JK, Schlichter LC. Neuron death and inflammation in a rat model of intracerebral hemorrhage: effects of delayed minocycline treatment. Brain Res 2007;1136:208-18.
197. Wu J, Yang S, Xi G, et al. Minocycline reduces intracerebral hemorrhage-induced brain injury. Neurol Res 2009;31:183-8.
198. Murata Y, Rosell A, Scannevin RH, et al. Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 2008;39:3372-7.
199. Alano CC, Kauppinen TM, Valls AV, et al. Minocycline inhibits poly (adp-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 2006;103:9685-90.
200. Chen-Roetling J, Chen L, Regan RF. Minocycline attenuates iron neurotoxicity in cortical cell cultures. Biochem Biophys Res Commun 2009;386:322-6.
201. Zhao F, Hua Y, He Y, et al. Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke 2011;42:3587-93.
202. Zhao F, Xi G, Liu W, et al. Minocycline attenuates iron-induced brain injury. Acta Neurochir Suppl 2016;121:361-5.
203. Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007;69:1404-10.
204. Fagan SC, Waller JL, Nichols FT, et al. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 2010;41:2283-7.
205. Switzer JA, Hess DC, Ergul A, et al. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke 2011;42:2633-5.
206. Switzer JA, Sikora A, Ergul A, et al. Minocycline prevents Il-6 increase after acute ischemic stroke. Transl Stroke Res 2012;3:363-8.
207. Kohler E, Prentice DA, Bates TR, et al. Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis. Stroke 2013;44:2493-9.
208. Poggiali E, Cassinerio E, Zanaboni L, et al. An update on iron chelation therapy. Blood Transfus 2012;10:411-22.
209. Abbruzzese G, Cossu G, Balocco M, et al. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica 2011;96:1708-11.
210. Arthur AS, Fergus AH, Lanzino G, et al. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Neurosurgery 1997;41:1385-91; discussion 1391-1382.
211. Sauerbeck A, Schonberg DL, Laws JL, et al. Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats. Exp Neurol 2013;248:53-61.
212. Cherny RA, Atwood CS, Xilinas ME, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in alzheimer's disease transgenic mice. Neuron 2001;30:665-76.
213. Kaur D, Yantiri F, Rajagopalan S, et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 2003;37:899-909.
214. Masuda T, Hida H, Kanda Y, et al. Oral administration of metal chelator ameliorates motor dysfunction after a small hemorrhage near the internal capsule in rat. J Neurosci Res 2007;85:213-22.
215. Horky LL, Pluta RM, Boock RJ, et al. Role of ferrous iron chelator 2, 2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 1998;88:298-303.
216. Wu H, Wu T, Li M, et al. Efficacy of the lipid-soluble iron chelator 2, 2'-dipyridyl against hemorrhagic brain injury. Neurobiol Dis 2012;45:388-94.
217. Caliaperumal J, Wowk S, Jones S, et al. Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats. Transl Stroke Res 2013;4:719-28.